{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15"],"submitter":["Gribben JG"],"pubmed_abstract":["Introduction
The objectives of this study were to identify key treatment attributes that drive physician and patient preferences for second line (2L) and third line (3L) treatments in relapsed/refractory (R/R) follicular lymphoma (FL).Methods
A multi- country, internet-based survey was administered to patients(N=195) with R/R FL and treating physicians (N=300) from the United States, United Kingdom, France, Germany, Brazil, and Japan. The survey included two discrete choice experiments - one for 2L and one for 3L treatment options - that prompted respondents to select their preferred option between two hypothetical treatment profiles varying on seven attributes associated with treatment for R/RFL: progression-free survival (PFS), overall survival (OS), serious adverse event"],"journal":["Frontiers in oncology"],"pagination":["1589722"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12287033"],"repository":["biostudies-literature"],"pubmed_title":["Patient and physician treatment preferences in relapsed/refractory follicular lymphoma: a discrete choice experiment in the United States, United Kingdom, France, Germany, Brazil, and Japan."],"pmcid":["PMC12287033"],"pubmed_authors":["Patel A","Kopenhafer L","Gribben JG","Beygi S","Ray M","Beusterien K","Will O","Ball G","Palivela M","Ghione P","Krupsky K","Best T","Bachy E"],"additional_accession":[]},"is_claimable":false,"name":"Patient and physician treatment preferences in relapsed/refractory follicular lymphoma: a discrete choice experiment in the United States, United Kingdom, France, Germany, Brazil, and Japan.","description":"Introduction
The objectives of this study were to identify key treatment attributes that drive physician and patient preferences for second line (2L) and third line (3L) treatments in relapsed/refractory (R/R) follicular lymphoma (FL).Methods
A multi- country, internet-based survey was administered to patients(N=195) with R/R FL and treating physicians (N=300) from the United States, United Kingdom, France, Germany, Brazil, and Japan. The survey included two discrete choice experiments - one for 2L and one for 3L treatment options - that prompted respondents to select their preferred option between two hypothetical treatment profiles varying on seven attributes associated with treatment for R/RFL: progression-free survival (PFS), overall survival (OS), serious adverse event","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025","modification":"2026-03-27T16:09:25.074Z","creation":"2025-08-30T03:05:44.898Z"},"accession":"S-EPMC12287033","cross_references":{"pubmed":["40708935"],"doi":["10.3389/fonc.2025.1589722"]}}